Dr Eitan Konstantino
Expanse Medical Inc.
ארצות הברית
Eitan Konstantino, PhD is Founder and CEO of Expanse Medical, a MedTech venture studio focused on significant unmet clinical needs. He has over 25 years of experience building medical device companies in the U.S. and Asia and holds nearly 200 patents and patent applications. Technologies developed by his teams have been acquired, licensed, or distributed by Medtronic, J&J, Stryker, Boston Scientific, Philips, Teleflex, and Genesis MedTech. He previously took QT Vascular public and served as CTO of Genesis MedTech.
Eitan Konstantino, PhD is a medical device inventor, entrepreneur, and Founder and CEO of Expanse Medical, a MedTech venture studio focused on solving significant unmet clinical needs and advancing innovative technologies through dedicated portfolio companies toward regulatory approval, commercialization, and strategic transactions. Its portfolio includes FlowPhysix, a commercial-stage vascular company with a direct U.S. sales force; Valorian Medical Technologies, developing a novel solution for erectile dysfunction; and a venture developing a new therapeutic platform for lymphatic disorders. Expanse also partners with leading medical device companies through its Build-to-Buy model, developing and de-risking technologies for strategic acquisition and integration. Dr. Konstantino has more than 25 years of experience creating and building medical device companies in the United States and Asia. He holds close to 200 patents and patent applications worldwide. His inventions include advanced stent technologies, the AngioSculpt® Scoring Balloon, Chocolate® balloon platforms, drug-device combination products, the FLOWRUNNER™ Aspiration System, and other technologies currently in development. Technologies developed by Dr. Konstantino and his teams have been acquired, licensed, or distributed by global medical device companies including Medtronic, Johnson & Johnson, Stryker, Boston Scientific, Philips, Teleflex, and Genesis MedTech. Prior to founding Expanse, Dr. Konstantino took QT Vascular public on the Singapore Exchange and served as CTO of Genesis MedTech. He earned his PhD in Mechanical Engineering from the Technion, Israel Institute of Technology and has served as Co-Chairman of an ASTM/FDA task force developing standards for endovascular devices.